Skip to content

Guangzhou Women's Health Cohort Study (GWHCS)

Guangzhou Women's Health Cohort Study (GWHCS)

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05506800
Enrollment
1000000
Registered
2022-08-18
Start date
2016-03-03
Completion date
2026-08-21
Last updated
2023-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cervical Cancer, Colorectal Cancer, Diabetes, Endometrial Cancer, Hypertension, Lung Cancer, Ovarian Cancer, Reproductive Disorder

Brief summary

The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.

Detailed description

The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.

Interventions

None listed

Sponsors

Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 35-64 years old * Women with registered permanent residence in Guangzhou * Women with informed consent

Exclusion criteria

* Women without informed consent * Women with reading and/or writing difficulties * Women with serious mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Incidence and mortality rate of cancerthrough study completion, an average of 2 yearsData from cancer registration platforms

Secondary

MeasureTime frameDescription
Hypertension and diabetesthrough study completion, an average of 2 yearsData from questionnaire
Reproductive healththrough study completion, an average of 2 yearsData from questionnaire

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026